To Top

Community

Andrew Ferraro

Andrew is a Wall Street veteran, with a track record and a focus on the drug discovery and biotechnology industry. He brings with him a considerable understanding and experience of the financial aspects of the life science business and markets, including 15 years working with biotech and drug discovery companies as well as small-molecule oncology therapies in phase II-III trials. He has a proven track record of developing and managing relationships in the financial and life sciences markets. He studied neurosciences at the University of Delaware.

Contribution
Biologics

Investment in Biopharma Facilities Continues

PMO-M11-16-NI-001
Outsourcing

Seeking Quality Deals: Consolidation and Acquisition

PAP-Q04-16-VP-002